Track LEXX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
LEXX - Lexaria Bioscience Corp (LEXX) has a earnings per share of -$0.08, up 61.9% over the past year.
Latest EPS (Actual)
-$0.08
Beat Rate
50.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| Jul 2026 | -$0.06 | -$0.08 | Miss | -33.33% |
| Apr 2026 | -$0.07 | -$0.06 | Beat | +14.29% |
| Jan 2026 | -$0.13 | -$0.07 | Beat | +46.15% |
| Oct 2025 | -$0.16 | -$0.14 | Beat | +9.68% |
| Jul 2025 | -$0.14 | -$0.21 | Miss | -50.00% |
| Apr 2025 | -$0.16 | -$0.15 | Beat | +6.25% |
| Jan 2025 | -$0.12 | -$0.16 | Miss | -33.33% |
| Nov 2024 | -$0.11 | -$0.15 | Miss | -36.36% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.